Biologika und niedermolekulare Wirkstoffe
z.B.
Abatacept (Orencia),
Adalimumab (Humira),
Anakinra (Kineret),
Apremilast (Otezla),
Certolizumab (Cimzia)
Etanercept (Enbrel),
Golimumab (Simponi),
Infliximab (Remicade, Inflectra, Remsima)
Rituximab (MabThera),
Tocilizumab (RoActemra),
Ustekinumab (Stelara),
Tofacitinib (Xeljanz)